SCHEMBL3205165

SCHEMBL3205165

CCOc1ccc(N(Cc2cccnc2)c2cccc(C(=O)OC(C)(C)C)c2)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
GRM2 Q14416 2/20 0.42
ALDH1A1 P00352 4/20 0.41
USP2 O75604 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SREBF1 P36956 1/20 0.40
QPCT Q16769 3/20 0.40
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
POLB P06746 1/20 0.39
PDK1 Q15118 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129630 0.93 MAPT (0.44) NPC1MAPTALDH1A1USP2NPSR1
SCHEMBL3125310 0.88 GRM2 (0.40) MAPTGRM2ALDH1A1PDE4APDE4B
SCHEMBL3129016 0.88 TSHR (0.50) NPC1MAPTGRM2ALDH1A1USP2
SCHEMBL3122799 0.88 PDE4B (0.42) MAPTGRM2ALDH1A1USP2NPSR1
SCHEMBL3128958 0.88 GRM2 (0.37) NPC1MAPTGRM2ALDH1A1ALOX15
SCHEMBL2910936 0.87 PDK1 (0.41) MAPTGRM2L3MBTL1QPCTPDK1
SCHEMBL2908090 0.87 PDK1 (0.42) GRM2ALDH1A1USP2NPSR1L3MBTL1
SCHEMBL2908204 0.86 MKNK1 (0.48) GRM2ALDH1A1USP2NPSR1L3MBTL1
SCHEMBL3126048 0.85 SREBF1 (0.41) NPC1MAPTALDH1A1L3MBTL1HSD17B10
SCHEMBL3129701 0.85 SREBF1 (0.40) NPC1MAPTALDH1A1NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B NPC1 3803/4885MAPT 4197/4885GRM2 3498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.